# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-04T02:02:29.529973
**Route:** OpenRouter + LaTeX
**Tokens:** 18766 in / 1496 out
**Response SHA256:** 5c507665ed8cb4cd

---

I reviewed the draft for the four categories of fatal errors you asked me to screen for. I found no issues rising to the level of a fatal error under your rules.

Summary of checks performed (high-level):
- Data-design alignment: Verified that the stated data coverage (WONDER D76 1999–2020 plus provisional 2021–2023 = 1999–2023 panel) is consistent with the treatment timing used in estimation (treatment cohorts through 2023; 2024–2025 adopters reclassified as not-yet-treated). The maximum treatment year used for treated cohorts (2023) does not exceed the maximum data year (2023). Post-treatment observation claims (up to 4 years post for 2020 adopters) are consistent with data coverage. Vermont is explicitly discussed as excluded from primary due to suppression and treated in sensitivity checks—this is internally acknowledged and handled.
- Regression sanity: The numerical values shown in-text/tables (examples provided in the appendix, e.g., ATT ≈ -0.117, SE ≈ 1.115) are plausible in magnitude for state-year mortality rates per 100k; there are no reported SEs or coefficients orders of magnitude larger than typical outcomes, no negative SEs, no R^2 outside [0,1], and no "NA"/"TBD"/"PLACEHOLDER" appearing in the substantive results as presented in the manuscript text. The manuscript explicitly documents approaches to inference (clustered SEs, CR2, wild bootstrap) and reports consistent results across them.
- Completeness: The paper reports sample sizes and describes the approximate number of observations in the working-age panel (≈1,100–1,200) and all-ages panel (≈1,157), describes suppressed cells handling, and includes descriptions of main and robustness tables and figures. There are no visible placeholders (NA/TBD/TODO) left in the main text, and the appendices describe implementation details (HonestDiD extraction fallback behavior, suppression sensitivity bounds, cohort lists). Policy-cohort tables and other exhibits are referenced and included via \input; the manuscript text describes them consistently.
- Internal consistency: Treatment definitions, coding conventions (first full calendar year as first_treat, mid-year convention), and control-group coding (first_treat = 0 for never- and not-yet-treated) are consistently described. The count of treated states (17) and the cohort composition sum (1 + 11 + 2 + 3 = 17) match. Exclusion of Vermont from primary and its inclusion in sensitivity checks is explicit and consistent.

Minor notes (non-fatal, informational):
- The manuscript uses CDC WONDER D76 for 1999–2020 and D176 for 2018–present, and states D76 is used as authoritative where overlapping; this strategy is reasonable and is transparently documented. (No fatal error.)
- There are many \input commands for external tables/figures. I assume those files are present and contain the numeric results the text refers to; I did not see any textual placeholders indicating missing table numbers or missing figures. If any of those external files are missing at submission time, compilation or missing-number issues would occur—but that is a submission/compilation issue rather than an internal-scientific fatal error in the content here.

Because I did not identify any data-design mismatches, broken regression outputs, missing required reporting elements, or internal contradictions that would constitute a fatal error under your checklist, I conclude the draft passes this fatal-error screening and can proceed to journal referee review.

ADVISOR VERDICT: PASS